Testicular Cancer

REVIEW UroToday

Young adult Latino testicular cancer survivors: a pilot study of Goal-focused Emotion regulation Therapy (GET). November 1, 2024

Comorbidities in Japanese testicular cancer survivors: A multi-institutional, cross-sectional study. October 31, 2024

New tumor markers for testicular cancer - in the here and now and in the future. October 28, 2024

The Utility of Immuno-Nutritional Scores in Patients with Testicular Germ Cell Tumors. October 21, 2024

Comparison of clinical characteristics of testicular tumor between children and adult population: a retrospective analysis. October 18, 2024

High-dose chemotherapy as initial salvage chemotherapy in patients with relapsed or refractory testicular cancer: a systematic review and meta-analysis. October 17, 2024

Short and long-term outcomes of arterial and caval replacement during postchemotherapy retroperitoneal lymph node dissection in metastatic testicular cancer. October 14, 2024

Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors. October 2, 2024

Radiological Assessment of Different Retroperitoneal Lymph Node Measurements in Stage 1 Testicular Cancer Patients: Impact on Clinical Stage and Treatment. September 30, 2024

Expression of Heat Shock Protein 90 in Testicular Cancer: A Retrospective Cohort Study. September 27, 2024

Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node Dissection. September 25, 2024

First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS). September 23, 2024

Aging-related biomarkers in testicular cancer survivors after different oncologic treatments. September 23, 2024

The expression of programmed cell death ligand 1 (PD-L1) involves in the clinicopathologic characteristics and prognostic implications of testicular germ cell tumor (TGCT): a systematic review and meta-analysis. September 20, 2024

Incidental testicular germ cell tumor in a transgender woman: A case report. September 18, 2024

Testicular cancer malpractice trends. September 18, 2024

Perioperative Serum MicroRNA 371a-3p and 372-3p Levels in Patients with Clinically Localized Testicular Masses. September 16, 2024

Primary retroperitoneal lymph node dissection in testicular germ cell cancer in clinical stage IIA/B-renaissance of an established treatment?. September 16, 2024

Cut-offs for relapse detection in men with stage I testicular germ cell tumors during active surveillance within a prospective multicentre cohort study using either raw or housekeeper normalized miR-371a-3p serum levels. September 13, 2024

Phosphokinases related to drug resistance in two cohorts from the cancer genome atlas (TCGA): uterine carcinoma and testicular cancer. September 12, 2024

Page 1 of 94